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Therapeutic targetA coxsackievirus B4 induces acute pancreatitis with different outcomes. The study utilized a systems biology
approach to identify molecular immune responses that differentiate between disease resolution and disease
progression. The data establish a temporal pattern of host responses that differentiate the resolution of acute
pancreatitis from the progression to chronic pancreatitis. A group of twenty-ﬁve genes exhibited character-
istic expression proﬁles that were observed during the development of chronic pancreatitis but not during
the resolution of disease. We postulate that the temporal dynamics of the twenty-ﬁve genes inﬂuence the de-
velopment of pathogenic immune responses associated with chronic pancreatitis. Furthermore, a subset of
eleven genes exhibited increased expression as viral titers waned. Of the eleven gene products, ﬁve are se-
creted molecules, TNF-α, IFN-γ, CXCL10, IL-10, and IL-22b, and represent novel potential therapeutic targets
since they can be readily modulated with antibodies against the speciﬁc cytokine/chemokine or with anti-
bodies against the corresponding receptors.
© 2012 Elsevier Inc. All rights reserved.Introduction
The most common result of infection with the group B coxsackie-
viruses (CVB) is asymptomatic infection, an undifferentiated febrile ill-
ness, or mild upper respiratory symptoms (Huber and Ramsingh,
2004). However, on rare occasions, CVB infection results in chronic in-
ﬂammatory disease of the pancreas, heart, or central nervous system
(Tracy and Gauntt, 2008). Since CVB infections range from asymptom-
atic infection to severe, debilitating chronic diseases, the study of viral
pathogenesis has proven challenging. The precise mechanisms by
which CVB cause acute or chronic inﬂammatory disease remain to be
determined. We have developed a mouse model of CVB4-induced pan-
creatitis to explore the molecular events at the virus/host interface that
affect the development of acute and chronic inﬂammatory disease
(Chapman et al., 1997; Huber and Ramsingh, 2004; Ramsingh, 2008).
Clinical pancreatitis is an inﬂammatory disease of the exocrine pan-
creas and occurs as either an acute or a chronic disease. Mild acute pan-
creatitis is generally self-limiting, while severe acute disease can lead
to a systemic inﬂammatory response syndrome with respiratory and
cardiovascular failure (Bhatia, 2004; Kingsnorth and O'Reilly, 2006;singh).
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rights reserved.Whitcomb, 2006). Chronic pancreatitis, on the other hand, is a painful
and debilitating disease, in which a progressive, destructive inﬂamma-
tory process destroys the exocrine pancreas, resulting in exocrine pan-
creatic insufﬁciency (Mergener and Baillie, 1997; Stevens et al., 2004).
Treatment is generally geared to reducing pain. Chronic pancreatitis
can develop from one episode of severe acute pancreatitis, or from re-
current episodes of acute disease. Furthermore, chronic pancreatitis is a
major risk factor for pancreatic cancer which has a poor prognosis.
Our experimental model utilizes a CVB4 variant designated CVB4-
V which induces a severe acute pancreatitis that progresses to chronic
pancreatitis (Ramsingh, 2008; Ramsingh et al., 1989). Acute pancrea-
titis develops during the period of viral replication while chronic pan-
creatitis develops after infectious virus is cleared. Chronic pancreatitis
resembles the clinical disease and is characterized by exocrine pan-
creatic insufﬁciency, weight loss, and pathological changes in the
pancreas (Ramsingh et al., 1999). We have shown that the severity
of acute pancreatitis is determined by the viral genotype. A single
amino acid residue in the DE-loop of the VP1 capsid is a major deter-
minant of viral virulence (Caggana et al., 1993). Additional studies
revealed that exogenously administered cytokines such as IL-12 or
IFN-γ modulate the severity of CVB4-V-induced acute pancreatitis
(Potvin et al., 2003). While the viral genotype determines the severity
of acute pancreatitis, host factors govern the progression to chronic
pancreatitis. We have recently shown that IL-10 plays a major role
in the development of chronic pancreatitis (Gu et al., 2009). CVB4-V
infection in IL-10 knockout (KO) mice or during disruption of IL-10
Fig. 1. Patterns of gene expression proﬁles after CVB4-V infection of BALB/c and IL-10 KO
mice. Three general patterns of gene expression (#1, #2, #3) were identiﬁed in the tran-
scriptional proﬁling studies. Genes displaying proﬁles #2B, #3A, and #3B were unique to
CVB4-V-infected BALB/c mice and were identiﬁed as correlates of disease progression.
Table 1
Genes that comprise a genetic signature of pathogenic immune responses associated
with the development of CVB4-V-induced chronic pancreatitis.
Gene Function
Toll-like receptors
Tlr2 Cell surface expression. Binds lipopeptides
Tlr4 Cell surface expression. Binds LPS
Tlr5 Cell surface expression. Binds proteins
Tlr7 Endosomal expression. Binds ssRNA
Tmed1/st2l Modulates innate immunity by inhibiting TLR signaling
TH17 responses
Il6ra IL-6 receptor subunit
Il6st/gp130 IL-6 receptor subunit
Tgfb1 TGF-β and IL-6 promote TH17 responses
Il17rb IL-17 receptor
Il8ra Receptor for IL-8/CXCL8 expressed on neutrophils
Tnfa Proinﬂammatory cytokine produced by macrophages and DCs
Iltifb/Il22b TH17 cytokine
RORγt Transcription factor for TH17 cells
TH1 responses
Socs5 Inhibits IL-4 signaling. Promotes TH1 responses
Ebi3/IL-27B Subunit of IL-27. Promotes TH1 responses
Ccl3/Mip1a Recruits activated T cells, NK, NKT, and macrophages.
Promotes TH1 responses
Ccr5 Receptor for CCL3, CCL4, and CCL5.
Promotes TH1 responses
Ifngr1 Receptor for IFN-γ
Ifng TH1 cytokine
Cxcr3 Receptor for CXCL9, CXCL10, and CXCL11.
Promotes TH1 responses
Cxcl10/
IP10
Chemotactic for T cells and monocytes
Tbet/Tbx21 Transcription factor for TH1 cells
Other
Gata3 Transcription factor for TH2 cells
Socs3 Involved in multiple signaling pathways. Inhibits JAK-STAT pathways
Il10 Regulatory cytokine. Generally considered anti-inﬂammatory
Table 2
Identiﬁcation of putative therapeutic targets based on sustained gene expression dur-
ing the late phase of disease. Genes encoding secreted molecules are in italics.
Expression
proﬁle
Genes encoding
Secreted molecules Transcription factors Receptors/signaling
2B Tnfa Gata3 Socs3
Ifng
Cxcl10
Il10
3B Il22b Tbet Tlr2
RORgt Cxcr3
136 R. Gu et al. / Virology 427 (2012) 135–143signaling in wild-type mice results in an acute pancreatitis that does
not progress to chronic pancreatitis. Cytokines have also been
shown to modulate myocarditis caused by CVB3. As was observed in
the CVB4 model, IFN-γ is protective during CVB3-induced acute myo-
carditis (Henke et al., 2001; Horwitz et al., 2000; Szalay et al., 2006).
Unlike the CVB4 model, IL-10 is beneﬁcial during CVB3-induced acute
myocarditis (Henke et al., 2001; Szalay et al., 2006). The results indi-
cate diversity in the mechanisms underlying CVB-induced disease
and caution against extrapolation from one model system to another.
Our initial studies to explore the molecular responses of the host to
CVB4-V infection utilized a systems biology approach to evaluate tran-
scriptional events during the early infectious phase of disease
(Ostrowski et al., 2004).We obtained a “snapshot” of the transcriptome
in the pancreas of infectedmice, at an early time in acute disease. CVB4-
V-induced acute pancreatitis was accompanied by increased expression
of genes involved in apoptosis, acinoductularmetaplasia, remodeling of
the extracellularmatrix, and ﬁbrosis; consistent with the observed pro-
gression to chronic pancreatitis. We subsequently pursued a study to
explore the temporal dynamics of molecular immune responses to
CVB4-V infection during the early infectious phase of disease and
showed that early high levels of IL-10 are associated with delayed in-
nate and adaptive immune responses in BALB/c mice (Gu et al., 2009).
The present study is an extension of this work and focuses on the tem-
poral dynamics of molecular immune responses to CVB4-V infection at
a later stage in the disease process, just prior to the development ofchronic pancreatitis. The goal of the study was to identify host molecu-
lar responses that correlated with progression to chronic disease. The
approach focused on comparing gene expression in two models, one
in which CVB4-V infection progresses to chronic inﬂammatory disease
(BALB/cmice) and another inwhichCVB4-V infection does not progress
to chronic disease (IL-10 knockout mice). We identiﬁed twenty-ﬁve
genes whose biphasic expression patterns correlated with disease pro-
gression. Of the twenty-ﬁve genes,ﬁve encode cytokines or chemokines
and represent novel potential therapeutic targets for the treatment of
chronic pancreatitis.
Results
Gene expression proﬁles associated with the development of
chronic pancreatitis
Pathological changes in our model of CVB4-V-induced chronic
pancreatitis in BALB/c mice have been extensively studied by our
137R. Gu et al. / Virology 427 (2012) 135–143group and include coagulative necrosis, generalized inﬂammation,
and acinoductular metaplasia against a background of ﬁbrosis
(Caggana et al., 1993; Ostrowski et al., 2004; Ramsingh et al., 1997;
Ramsingh et al., 1999). Unlike BALB/c mice, CVB4-V infection of IL-
10 KO mice results in a moderate pancreatitis that resolves without
further progression. By 21 dpi, the exocrine tissues of IL-10 KO mice
show almost complete recovery and contain abundant intact acini
(Gu et al., 2009).
A longitudinal study of gene expression during CVB4-V infection
of IL-10 KO or BALB/c mice was undertaken to identify differences
in gene expression during the early infectious phase of disease and
during the later phase of disease. The approach relied on monitoring
the expression of inﬂammatory markers and T cell markers, using a
PCR-based assay in a low-density microarray format. The expression
of 46 test genes in pancreatic tissues was evaluated at various time
points after CVB4-V infection of BALB/c and IL-10 KO mice. GenesFig. 2. Relative change in expression proﬁles of functional groupings of genes after CVB4-V in
ing consisting of three genes, Gata3, Socs3, and Il10. Three-to-ﬁve mice per strain were ana
TaqMan Gene Expression Assay in a two-step RT-PCR and a low-density array. The Ct value o
for samples at each time point were averaged. The change in gene expression, for both BALB/
reference group which is BALB/c mice at 2 dpi. As a result, the relative expression of a geneinvolved in inﬂammatory responses included Toll-like receptors
(TLRs), CC chemokines, CXC chemokines, and markers expressed by
macrophages, neutrophils, and natural killer (NK) cells. Genes in-
volved in T cell responses included T-cell associated cytokines and
transcription factors for TH17, TH1, TH2, and T reg cells. Differences
in gene expression during the early infectious phase of disease have
already been reported (Gu et al., 2009). The present study focuses
on differences in gene expression during the later phase of disease,
just prior to the development of chronic pancreatitis or to the resolu-
tion of acute disease.
Both the magnitude and the pattern of gene expression differed
between CVB4-V-infected-BALB/c and IL-10 KO mice during the
later phase of disease. All 46 test genes were expressed at higher
levels in BALB/c mice than in IL-10 KO mice. Proﬁles of the 46 genes
fell into three general categories (Fig. 1). Proﬁle #1 shows a mono-
phasic pattern with peak expression occurring during the early viralfection of BALB/c and IL-10 KOmice. A. TLR related grouping; B. A miscellaneous group-
lyzed at each time point and gene expression in the pancreas was quantiﬁed using the
f each test gene was normalized to an endogenous control, egf, and the [delta] Ct values
c and IL-10 KOmice, is represented as a fold-change relative to the expression level of a
in BALB/c mice at 2 dpi is 1. Closed circles, BALB/c mice; open circles, IL-10 KO mice.
138 R. Gu et al. / Virology 427 (2012) 135–143phase of disease. Proﬁle #2 shows a biphasic pattern with higher ex-
pression during the early viral phase of disease. There were two var-
iations of proﬁle #2. Proﬁle #2A shows decreasing gene expression
during the late viral phase of disease (between 10 dpi and 14 dpi),
while proﬁle #2B shows increasing gene expression during the
same time interval. Proﬁle #3 also shows a biphasic pattern but
with higher expression during the late viral phase of disease. Proﬁle
#3 again had two variations. Proﬁle #3A shows decreasing gene ex-
pression between 10 dpi and 14 dpi while proﬁle #3B shows increas-
ing gene expression during the same time interval. Proﬁles #1 and
#2A were common to infected BALB/c and IL-10 KO mice while pro-
ﬁles #2B, #3A, and #3B were unique to infected BALB/c mice. Because
the latter three proﬁles were speciﬁc to mice that progressed to
chronic inﬂammatory disease, we identiﬁed the 25 genes displaying
these proﬁles as contributing to the development of chronic pancrea-
titis (Table 1). The proﬁles of two of these genes (Cxcl10 and Tnfa)
have been previously reported (Gu et al., 2009).Fig. 3. Relative change in expression proﬁles of TH17 related genes after CVB4-V infection o
point and gene expression in the pancreas was quantiﬁed using the TaqMan Gene Expression
normalized to an endogenous control, egf, and the [delta] Ct values for samples at each tim
relative to the expression level of a reference group. For all genes except RORγt, the referenc
the relative expression of a gene, except for RORγt, in BALB/c mice at 2 dpi is 1. The relati
circles, IL-10 KO mice.Markers of TLRs, TH17, and TH1 responses are associated with the
development of chronic pancreatitis
The genetic signature associated with the development of chronic
pancreatitis in BALB/c mice includes 6 genes exhibiting proﬁle #2B,
14 genes exhibiting proﬁle #3A, and 5 genes exhibiting proﬁle #3B.
Eleven genes exhibited proﬁle #2B or #3B which is characterized
by increasing expression during the second week of infection when
viral titers were diminishing (Table 2). High expression of the
group of 11 genes correlates with progression to chronic
pancreatitis.
In IL-10 KO mice, all expression proﬁles returned to baseline
14 days after infection. The 25 genes were sorted into three func-
tional groups; one group of genes encodes TLRs, another group en-
codes markers of TH17 responses while a third group encodes
markers of TH1 responses. A miscellaneous group contains three
genes. The TLR group contains 5 genes, Tlr2, Tlr4, Tlr5, Tlr7, andf BALB/c and IL-10 KO mice. Three-to-ﬁve mice per strain were analyzed at each time
Assay in a two-step RT-PCR and a low-density array. The Ct value of each test gene was
e point were averaged. The change in gene expression is represented as a fold-change
e group is BALB/c at 2dpi. For RORγt, the reference group is BALB/c at 4 dpi. As a result,
ve expression of RORγt in BALB/c mice at 4 dpi is 1. Closed circles, BALB/c mice; open
139R. Gu et al. / Virology 427 (2012) 135–143Tmed1, all of which exhibited proﬁle #3A except Tlr2 which dis-
played proﬁle #3B (Fig. 2A). Three genes in the “other” category,
gata3, socs3, and il10, all displayed proﬁle #2B (Fig. 2B).
The TH17 group contains 8 genes exhibiting three different ex-
pression proﬁles. One gene, Tnfa, displayed proﬁle #2B, while 5
genes, Il6ra, Il6st, Tgfb1, Il17rb, and Il8ra, exhibited proﬁle #3A and
two, Iltifb/Il22b and RORγt, showed proﬁle #3B (Fig. 3). The sus-
tained presence of TH17 cells in the pancreatic inﬁltrates of BALB/c
mice, as viral titers decreased, is inferred from the expression of
(a) RORγt (a transcription factor for TH17 cells), the IL-6 receptor,
and IL-22B; (b) an IL-17 receptor, which is expressed on a variety of
cells involved in proinﬂammatory responses; and (c) the IL-8 recep-
tor, which is expressed on neutrophils.
The TH1 group contains 5 genes, Socs5, Ebi3/IL-27B, Ccl3, Ccr5,
and Ifngr1, which exhibited proﬁle #3A while two, Cxcr3 and T-bet
showed proﬁle #3B and another two, ifng and CxCl10, showed proﬁle
#2b (Fig. 4). The sustained presence of TH1 cells in the pancreatic in-
ﬁltrate as viral titers decreased is inferred from the expression of
(a) T-bet (a transcription factor for TH1 cells), and the IFN-γ receptor;Fig. 4. Relative change in expression proﬁles of TH1 related genes after CVB4-V infection of B
and gene expression in the pancreas was quantiﬁed using the TaqMan Gene Expression As
normalized to an endogenous control, egf, and the [delta] Ct values for samples at each
change relative to the expression level of a reference group, CVB4-V-infected BALB/c at 2 dpi
BALB/c mice; open circles, IL-10 KO mice.(b) CCL3, which recruits activated T cells and macrophages; and
(c) CCR5 and CXCR3, which are expressed on activated T cells and
macrophages.
Measurement of cytokines in pancreatic tissues of CVB4-V-infected mice
To conﬁrm the gene array data, we measured the protein concen-
tration of four secretedmolecules (CXCL10, TNF-α, IFN-γ, and IL-10),
in pancreatic tissues of CVB4-V-infected BALB/c mice or IL-10 KO
mice (Fig. 5). The overall kinetics of protein expression was similar
to the kinetics of RNA expression. However, while both the protein
and RNA proﬁles for TNF-α showed higher expression in BALB/c
than in IL-10 KO mice throughout the infection (Fig. 5B), protein
and RNA proﬁles for CXCL10 and IFN-γ showed some differences.
For example, the RNA data indicate that CXCL10 expression was
higher in BALB/c mice throughout the infection (Fig. 4) while the
protein data shows that CXCL10 expression was higher in BALB/c
mice except at 2 and 4 dpi when expression levels were similar be-
tween the two strains of mice (Fig. 5A). Similarly, the RNA data indi-
cate that IFN-γ expression was higher in BALB/c throughout theALB/c and IL-10 KOmice. Three-to-ﬁve mice per strain were analyzed at each time point
say in a two-step RT-PCR and a low-density array. The Ct value of each test gene was
time point were averaged. The change in gene expression is represented as a fold-
. As a result, the relative expression of a gene in BALB/c mice at 2 dpi is 1. Closed circles,
Fig. 5. Kinetics of expression of four cytokines, CXCL10, TNF-α, IFN-γ, and IL-10, in the pancreas of CVB4-V-infected BALB/c or IL-10 KO mice. Three-to-ﬁve mice per strain were
analyzed at each time point and the amount of cytokines/chemokines present in pancreatic homogenates was measured using a Luminex assay. Mean values are shown. The overall
kinetics of protein expression in both strains of mice is similar to that of the corresponding RNA. Statistical analysis was done using the Mann–Whitney U test. Statistically signif-
icant differences (Pb0.05) in protein expression between the two mouse strains are indicated by asterisks.
140 R. Gu et al. / Virology 427 (2012) 135–143infection (Fig. 4). The protein data shows that IFN-γ expression was
higher in BALB/c mice at 2, 6, 8, and 10 dpi (Fig. 5C). However at
4 dpi, IFN-γ expression was higher in IL-10 KO mice.Fig. 6. Simultaneous administration of anti-TNF-α and anti-IFN-γ antibodies had a beneﬁ
eosin-stained pancreatic sections from CVB4-V infected mice. A. Normal pancreatic tissue
mice depicting chronic pancreatitis characterized by exocrine tissue destruction and inﬂam
Exocrine tissues are largely intact and inﬂammation is absent. D. Pancreatic tissue from CVB
foci of normal acini are present. A, acinus; IL, islet of Langerhans; f, fat replacement; an, aciImmunomodulation using anti-cytokine antibodies
To determine whether the systems approach had uncovered rele-
vant therapeutic targets, we undertook a pilot study to down-regulatecial effect on chronic pancreatitis. Panels A–D depict representative hematoxylin and
from mock-infected BALB/c mice. B. Pancreatic tissue from CVB4-V infected BALB/c
mation. C. Pancreatic tissue from CVB4-V infected IL-10 KO showing disease resolution.
4-V-infected BALB/c mice treated with anti-TNF-α and anti-IFN-γ antibodies. Multiple
nar cell necrosis; in, inﬂammatory inﬁltrates. Magniﬁcation, ×250.
141R. Gu et al. / Virology 427 (2012) 135–143identiﬁedmolecules.We targeted secretedmolecules (Table 2) because
these can be down-modulated using speciﬁc antibodies. An extensive
analysis of all of the identiﬁed targets was beyond the scope of the pre-
sent study. Of the ﬁve secreted molecules, we targeted two cytokines,
TNF-α and IFN-γ, because of their pleiotropic effects. Micewere treated,
from eight to fourteen days after CVB4-V infection, with a combination
of anti-TNF-α and anti-IFN-γ antibodies. Body weight and pathology
were used as indicators to monitor the course of disease. At the end of
the four-week follow-up period, the overall weight gain in the dual an-
tibody treated group was 20% compared to 5% in the untreated group.
The pathology results corroborate the body weight data. Pancreatic tis-
sues from controls showed extensive destruction characterized by fat
replacement of destroyed acini, acinar cell necrosis, acinoductular
metaplasia, rare foci of normal acini, and inﬂammation (Fig. 6B). Al-
though some exocrine tissue loss was observed in mice treated with
anti-TNF-α and anti-IFN-γ, all ﬁvemice showedmultiple foci of normal
acini (Fig. 6D), similar to the overall histology observed in IL-10KOmice
(Fig. 6C).
Discussion
In this study, the data establish a temporal pattern of molecular
immune responses that differentiate the resolution of acute pancrea-
titis from the progression to chronic pancreatitis. We identiﬁed a
group of twenty-ﬁve immune-related genes (Table 1) with character-
istic expression proﬁles that were observed during the development
of chronic pancreatitis but not during the resolution of disease. We
postulate that the temporal dynamics of the group of twenty-ﬁve
genes contribute to the development of pathogenic immune re-
sponses associated with chronic pancreatitis. Furthermore, a subset
of eleven genes (Table 2) exhibited increased expression as viral ti-
ters waned. Of the eleven gene products, ﬁve are secreted molecules,
TNF-α, IFN-γ, CXCL10, IL-10, and IL-22b, and represent potential
therapeutic targets since they can be readily modulated with anti-
bodies against the speciﬁc cytokine/chemokine or with antibodies
against the corresponding receptors. In a pilot study, we showed
that treatment of CVB4-V-infected mice with both anti-IFN-γ and
anti-TNF-α antibodies proved beneﬁcial since treated mice gained
weight and showed multiple foci of normal acini in the pancreas.
The data provide support for the therapeutic potential of antibodies
against the identiﬁed cytokines/chemokines.
The molecular immune responses that differentiate the resolution
of acute pancreatitis from the progression to chronic pancreatitis in-
clude TLR, TH17, and TH1 responses (Table 1). TLR signaling via
MyD88 can activate NF-κB, leading to a proinﬂammatory response
due to transcription of numerous genes, including those encoding cy-
tokines and chemokines (Liu and Malik, 2006). The genetic signature
associated with the development of chronic pancreatitis contains sev-
eral genes that are NF-κB dependent, including Tnfa, Cxcl10, and Ccl3/
Mip1a. NF-κB activation is also inferred by the expression of cytokine
and chemokine receptors, IL-6ra/st and CCR5. While TLR4 and TLR7
have been identiﬁed by others (Triantaﬁlou et al., 2005) as initiating
the inﬂammatory response during CVB infection, the present report
also links TLR2 and TLR5 to CVB infection. Increased expression of
TLR2, TLR4, and TLR5 indicates either that CVB4 virions bind to
these surface receptors or else that up-regulation of the receptors is
a result of the host's response to infection. The prolonged presence
of TH17 cells in the pancreas, during progression to chronic disease,
is inferred from the high and sustained expression of Il22b/Iltifb and
the transcription factor, RORγt. High expression of the IL-6 receptor,
TGF-β, the IL-17 receptor (IL-17RB), and IL-8RA provides further evi-
dence of a TH17 response in the pancreas. In addition, the prolonged
presence of TH1 cells in the pancreas during progression to chronic
disease is inferred by the high and sustained expression of Ifng,
Ifngr1, Socs5, and the transcription factor, Tbet (Table 1). Further ev-
idence of a TH1 response is provided by the high levels of expressionof chemokines, Ccl3 and Cxcl10, and chemokine receptors, Ccr5 and
Cxcr3 (Table 1).
In a well-regulated response to infection, innate immune re-
sponses (TLR activation, macrophage and neutrophil recruitment,
NK and NKT activation) control the early stage of infection, until
adaptive immune responses develop. As the infection is cleared,
adaptive immune responses subside. The prolonged high expression
of TLR, TH17, and TH1 markers in CVB4-V-infected BALB/c mice, dur-
ing the period of viral clearance, indicates that the temporal sequence
of immune responses was disrupted. The aberrant gene expression
proﬁles were observed only in BALB/c mice which progress to chronic
pancreatitis and not in IL-10 KO mice which resolve acute disease. In
IL-10 KO mice, the expression of TLR, TH17, and TH1 markers
returned to baseline levels during the late viral phase of disease, indi-
cating a well-regulated immune response to CVB4-V infection. The
data suggest that as virus is cleared, innate and adaptive immune re-
sponses remain in the “on” position in CVB4-V-infected BALB/c mice
and are switched off in CVB4-V-infected IL-10 KO mice.
Of the ﬁve potential therapeutic targets identiﬁed in this study,
IFN-γ appears to have a dual role in CVB4-V-induced pancreatitis.
During the acute stage of CVB4-V-induced pancreatitis, the IFN-γ re-
sponse in BALB/c mice is delayed, with peak RNA and protein expres-
sion at 6 dpi compared to a peak response at 4 dpi in IL-10 KO mice.
We have previously shown that early high expression of IL-10 corre-
lates with delays in overall innate and T cell responses (Gu et al.,
2009). Early treatment with IFN-γ attenuates the severity of CVB4-
V-induced acute pancreatitis in BALB/c mice (Potvin et al., 2003); pre-
sumably by overcoming the delays in ensuing immune responses. In
the present work, as viral titers diminished, sustained IFN-γ correlated
with progression to chronic inﬂammatory disease and down-
modulation of IFN-γ, later in the disease, was beneﬁcial. The combined
data highlights the need for greater understanding of the pathogenesis
of chronic pancreatitis and the challenges in designing immunomodula-
tory approaches since a cytokine that is beneﬁcial at one stage of disease
may be detrimental at a later stage.
In this study, IL-10 was also identiﬁed as a potential therapeutic tar-
get. This is a surprising result since IL-10 is generally considered to be an
anti-inﬂammatory cytokine (Couper et al., 2008; Pestka et al., 2004).
We have previously shown that early high production of IL-10 corre-
lates with altered kinetics of regulatory T cell responses indicative of a
disruption in the balance between effector and regulatory T cell re-
sponses (Gu et al., 2009). The association of high IL-10with the progres-
sion to chronic disease may reﬂect the ongoing disruption between
effector and regulatory T cell responses. We have previously shown
that down-regulation of IL-10 early in CVB4-V infection is beneﬁcial
(Gu et al., 2009). Future studies will determine whether down-
regulation of IL-10 later in infection alters the course of chronic disease.
A systems biology approach allowed us to identify a genetic signa-
ture of immune responses that correlated with disease progression
and to uncover ﬁve potential therapeutic cytokine targets for the treat-
ment of chronic pancreatitis. The data also highlight the complexity of
the disease process that ultimately results in chronic pancreatitis and
the need for caution in designing immunomodulatory approaches for
the treatment of chronic pancreatitis.
Materials and methods
Cells, viruses, and mouse strains
CVB4-V is a pathogenic variant that was selected after multiple
passages of the JVB strain of CVB4 in mouse pancreas (Ramsingh et
al., 1989). A large-scale stock of plaque-puriﬁed virus was grown in
LLC-MK2(D) cells and viral infectivity was measured by plaque
assay. Two strains of mice were used in this study. BALB/c mice, pur-
chased from The Jackson Laboratory (Bar Harbor, ME), were housed
in a Speciﬁc Pathogen Free (SPF) facility at the Wadsworth Center
142 R. Gu et al. / Virology 427 (2012) 135–143(Albany, NY). IL-10 KO mice on the C57BL/6 genetic background were
bred onto the BALB/c background (Dr. William Lee at the Wadsworth
Center) for 11 generations. After 10 generations of traditional back-
crossing, the recipient genome is 99.9% (www.criver.com). Thus,
after 11 generations, the IL-10 KO mice have greater than 99.9% of
the BALB/c genetic background.
Five-to-six week old mice (14–20 g) were used in the study. Mice
were infected intraperitoneally with CVB4-V and were allowed to eat
and drink ad libitum. Because male mice develop a more severe acute
disease than female mice (Ramsingh et al., 1999), male mice were
infected with 103 pfu of virus while female mice were given 104 pfu
of virus. Mice were sacriﬁced at various time points after infection
and organs were removed. Pancreatic tissues were ﬁxed in Bouin's
solution (Sigma-Aldrich, St. Louis, MO), processed for routine histol-
ogy, and stained with hematoxylin and eosin. All animal procedures
were approved by the Institutional Animal Care and Use Committee
(IACUC) of the Wadsworth Center.
Isolation of pancreatic RNA
Pancreatic tissues were harvested at various time points after in-
fection. Tissues were frozen immediately on dry ice and placed in
TRI reagent (Molecular Research Center, Inc. Cincinnati, OH) which
combines phenol and guanidine thiocyanate in amono-phase solution
to inhibit RNase activity. Tissues were homogenized in a mini-beater
(Biospec Products, Bartlesville, OK) using 1 mm Zirconia beads (Bios-
pec Products). After a clarifying spin at 10,000×g for 10 min at 4°,
the homogenate was separated into aqueous and organic phases by
the addition of 1-bromo-3-chloropropane (BCP) (Molecular Research
Center) and centrifugation. RNA was precipitated from the aqueous
phase by the addition of isopropanol, washedwith ethanol, and resus-
pended in water. Residual DNA was digested with DNase (Promega,
Madison,WI) and puriﬁed RNAwas obtained using an RNeasy column
(Qiagen, Valencia, CA).
Measurement of cytokines and chemokines in pancreatic homogenates
The pancreas, harvested at various times after infection, was frozen
immediately on dry ice and placed in 1 ml of lysis buffer containing
protease inhibitors (50 mM Tris, 150 mM NaCl, 2 mM EDTA, 1%
NP40, 30 μM PMSF, 420 μM leupeptin, 0.02% aprotinin, 3 mM NaN3)
(Gu et al., 2009). Organs were homogenized in a mini-beater (Biospec
Products, Bartlesville, OK) using 1 mm Zirconia beads (Biospec Prod-
ucts). The homogenate was centrifuged at 10,000×g for 10 min at
4 °C and the supernatants were stored at−80 °C. Cytokines and che-
mokines in the pancreatic homogenates were measured using a mul-
tiplex bead-based assay, Luminex (Invitrogen), according to the
manufacturer's protocol. Three-to-six organs were analyzed at each
time point.
Gene expression in pancreatic tissues of CVB4-V-infected mice
Gene expression was quantiﬁed using the TaqMan Gene Expres-
sion Assay in a two-step RT-PCR and a TaqMan Low Density Array
(LDA), a 384-well micro ﬂuidic card, preloaded with appropriate PCR
primers and probes (Applied Biosystems) (Gu et al., 2009). Total pan-
creatic RNAwas reverse-transcribedwithM-MLVRT and randomhex-
amers in a reaction volume of 25 μl using standard conditions. Brieﬂy,
random hexamers (Invitrogen, Carlsbad, CA) were added to 3 μg total
RNAwhich was denatured at 90 °C. Samples were frozen immediately
on dry ice and thawed slowly on ice. After the addition of a cocktail
containing dNTPs (1 mM) (Roche, Switzerland), RNasin (Promega,
Madison, WI), DTT (0.1 M), and M-MLV RT, the reaction was incubat-
ed at 37 °C, heat-inactivated at 70 °C, and cDNAs were stored
at −80 °C. 100 ng of cDNA was mixed with Taqman Fast Universal
PCR Master Mix (Applied Biosystems) to a ﬁnal 1× concentrationand approximately 2 ng of the cDNA solution was applied to each of
48 wells in the LDA card. PCR ampliﬁcation was carried out in an Ap-
plied Biosystems 7900HT Fast Real-Time PCR System. Eight pancreatic
samples was analyzed simultaneously for the expression of 47 genes
and 18S ribosomal RNA in one 384-well LDA card. The LDA card con-
tained three possible controls, 18S RNA, Egf, and Slc2a2/Glut-2. The
expression of Egf remained unchanged during CVB4-V infection
while the expression of both 18S RNA and Slc2a2 varied over the
course of the infection. As a result, expression of test genes was nor-
malized to that of Egf. The expression of one additional gene, RORγt,
not present on the LDA card, was quantiﬁed using the TaqMan Gene
Expression Assay in a two-step RT-PCR in a single-tube format with
the Applied Biosystems 7500 Real-Time PCR System. The expression
of RORγt was again normalized to that of Egf.
Analysis of gene expression data
The study focused on pancreatic gene expression at multiple time
points (1, 2, 4, 6, 8, 10, and 14 days post infection (dpi)) in two treat-
ment groups, CVB4-V-infected BALB/c mice and CVB4-V-infected IL-
10 KO mice. Three-to-ﬁve mice per strain were analyzed at each
time point and gene expression was quantiﬁed by a comparative Ct
method (Applied Biosystems). The Ct value of each test gene in
each organ was normalized to that of the control gene, Egf. The result-
ing [delta] Ct values for samples from each time point were then av-
eraged. Since the goal of the study was to evaluate the magnitude of
gene expression over time within a single treatment group and be-
tween treatment groups, a reference group was needed. The refer-
ence group chosen for all except one test gene was CVB4-V-infected
BALB/c mice, 2dpi, because gene expression was very low or unde-
tectable prior to this time point. For the one exception, RORγt, the ref-
erence group was CVB4-V-infected BALB/c mice at 4 dpi because gene
expression was undetectable prior to this time point. The change in
gene expression is represented as a fold-change which was calculated
by determining 2−ddCt (ddCt=averaged [delta]Ct (speciﬁc time point)−
averaged [delta]Ct BALB/c 2 dpi). As a result, for all genes except
RORγt, the relative expression in CVB4-V-infected BALB/c mice at
2 dpi is 1. For RORγt, the relative expression in CVB4-V-infected
BALB/c mice at 4 dpi is 1. By using the BALB/c reference for both the
BALB/c mice and the IL-10 KO mice, we were also able to assess the
relative magnitude of gene expression in the two strains.
Treatment of CVB4-V-infected mice with anti-cytokine antibodies
A pilot study was undertaken to assess whether the systems biol-
ogy approach had uncovered relevant targets. We focused on two of
the ﬁve potential targets, TNF-α and IFN-γ, because of their pleiotro-
pic effects. In this initial study, we tested a combination of anti-TNF-α
and anti-IFN-γ, in ﬁve CVB4-V-infected mice. Antibodies were admin-
istered intraperitoneally. Anti-TNF-α (Centocor, PA) and anti-IFN-γ
(BioXCell, W. Lebanon, NH) were each administered at a dose of
0.5 mg at 8, 10, and 14 dpi. CVB4-V-infected mice in the control
group were treated with an isotype control antibody. Mice were
weighed daily for a 4-week follow-up period. At the end of 4 weeks,
mice were sacriﬁced and pancreatic tissues were processed for rou-
tine histology.
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